NCT05924672 2026-01-14
Efficacy of Ra-223 in PSMA PET Optimally Selected Patients
University of California, San Francisco
Phase 2 Active not recruiting
Clinical Trials
3 trialsNCT05614518 2022-11-14
Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTcâMDP-BS±SPECT
HTA Co., Ltd.
Phase 3 Completed
NCT00956163 2014-07-02
Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Completed